The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Dedicated to enhancing knowledge and skill in the care of the allergic patient."
The Centers for Medicare & Medicaid Services (CMS) released the proposed 2018 Medicare Physician Fee Schedule (MPFS).…
Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA). Read More
CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More
Why attend the 2018 AAOA Annual Meeting in Philadelphia from September 14-16? Learn some of the reasons to attend from the AAOA Leadership and staff. Register
What is it in today’s otolaryngology practice that is resonating as a hot topic? Where are the novel treatment strategies? What is today’s typical otolaryngology practice or more specifically the typical AAOA member’s practice? These are the questions we try to address when building out our Advanced Course in Allergy & Immunology. Read More
CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More
Editor in Chief Search
The ARS-AAOA IFAR LLC is pleased to announce its search for Editor in Chief, term beginning April 2020. Read More
IFAR Impact Factor: 2.135
2018 AAOA Annual Meeting
September 14-16 | Philadelphia, PA
Learn More and Register
2018 Advanced Course in Allergy & Immunology
December 6-8 | Atlanta, GA
Learn More and Register
AAOA Clinical Insights
Learn More and Register
The first most basic treatment step, once an allergen has been identified, is to eliminate or avoid contact with it, if possible. Unfortunately, avoiding some allergens (such as dust, molds, and animals) is often difficult and thus allergen avoidance alone may not be effective.
Nationwide shortage of Sterile Water for Injections is affecting multiple manufacturers. Some Specialty Pharmacies are…
Building off the success of our radically re-designed Chicago Annual Meeting, we look forward to…
By Cecelia Damask, DO, Director of Educational Programs Due to popular demand, the AAOA is excited…
An updated draft of USP Chapter 797 was released today.…
The second year of the Quality Payment Program (QPP) authorized…